Atrial septal defect {#sec1-1}
====================

Atrial septal defect is a persistent interatrial communication ([@ref1]). It is the second most common congenital heart defect and accounts for approximately 10% of all cardiac malformations. It includes ostium secundum (\~75% of cases), ostium primum (15-20%) and sinus venosus (5-10%) ([@ref1]). It is detected in 1:1500 live births, with a female-to-male ratio of 2-4:1. Its estimated prevalence in the general population is 1:25000 ([@ref2]). Atrial septal defect is often associated with paradoxical embolism, cerebral abscess, pulmonary hypertension, conduction disturbances, cardiomyopathies, complex congenital heart defect and sudden cardiac death ([@ref3]).

Clinical course is variable and depends on the size of the malformation. Most very small atrial septal defects (diameter \<5 mm) do not have clinical consequences, whereas a defect of 5-10 mm may lead to symptoms in the fourth or fifth decade of life. Larger defects (generally \>10 mm) typically present with symptoms in the third decade of life ([@ref3]).

Clinical diagnosis is based on patient history, physical examination, two-dimensional transthoracic echocardiography and transesophageal echocardiogram, cardiac computed tomography and magnetic resonance imaging ([@ref4],[@ref5]). Differential diagnosis should consider Klippel-Feil syndrome and Eisenmenger syndrome, which features systolic flow murmur in the pulmonary valve region due to increased pulmonary flow ([@ref6], [@ref7]).

Atrial septal defect is almost always sporadic, but familial cases have been reported. The disease has autosomal dominant inheritance with reduced penetrance, variable expressivity and genetic heterogeneity of familial atrial septal defects ([@ref7]) ([Table 1](#T1){ref-type="table"}).

###### 

Genes associated with various forms of atrial septal defect

  Gene       OMIM gene   Disease                   OMIM disease   Inheritance   Function
  ---------- ----------- ------------------------- -------------- ------------- -------------------------------------------------------------------------------------------------------------------------------------
  *GATA4*    600576      ASD2                      607941         AD            Regulation of genes involved in myocardial differentiation and function
  *TBX20*    606061      ASD4                      611363         AD            Transcriptional activator and repressor required for heart development, and for functional and structural phenotypes in adult heart
  *MYH6*     160710      ASD3                      614089         AD            Alpha heavy chain subunit of cardiac myosin
  *ACTC1*    102540      ASD5                      612794         AD            Major constituent of contractile apparatus of muscle tissue
  *TLL1*     606742      ASD6                      613087         AD            Essential for interventricular septum formation
  *NKX2-5*   600584      ASD7, with/without AVCD   108900         AD            Transcription factor necessary for heart formation and development
  *CITED2*   602937      ASD8                      614433         AD            Regulatory gene indispensable for prenatal development
  *GATA6*    601656      ASD9                      614475         AD            Important in gut, lung and heart development
  *NKX2-6*   611770      ASD                       /              AD            Role in embryonic development of heart in conjunction with NKX2-5

ASD=atrial septal defect; AVCD=atrioventricular conduction defects; AD=autosomal dominant.

MAGI uses a multi-gene NGS panel to detect nucleotide variations in coding exons and flanking introns of the above genes.

Other authors have reported sensitivities of 90% and 100% in 11 ventricular septal defects and five atrial septal defects, respectively ([@ref8]) and 80% sensitivity in a combined series of 10 atrial septal defects and ventricular septal defects ([@ref9]).

Supravalvular aortic stenosis {#sec1-2}
=============================

Supravalvular aortic stenosis (SVAS) is a congenital narrowing of the lumen of the ascending aorta ([@ref10]). It is often associated with stenosis of other vessels, typically the pulmonary artery, and also with arrhythmia. It may occur as an isolated condition or as a feature of syndromes such as Williams-Beuren ([@ref11]) or cutis laxa syndrome ([@ref12]). Its severity varies: some affected patients never experience symptoms and others die in infancy. Although clinical presentation is heterogeneous and severity is variable, surgical treatment is often needed. If not treated, aortic stenosis may lead to dyspnea, chest pain and heart failure. Supravalvular aortic stenosis has an incidence of 1:20000 newborns ([@ref13]) and a prevalence of 1:7500.

Clinical diagnosis is based on patient history, physical examination, echocardiography, electrocardiography and angiographic evidence of progressive narrowing of the aorta and/or pulmonary artery lumen ([@ref14]). Differential diagnosis should consider Williams-Beuren syndrome, in which SVAS is identical to the isolated form but associated with behavioral disorders, typical facial features and hypercalcemia ([@ref15]).

Supravalvular aortic stenosis is either sporadic or familial and has autosomal dominant inheritance with reduced penetrance and variable expressivity. It is associated with more than 60 variations in the ELN gene (OMIM gene 130160; OMIM disease 185500) ([@ref16]). Pathogenic variants may be missense, nonsense, splicing or small indels. Large deletions/duplications have also been reported in the ELN gene. MAGI uses NGS to detect nucleotide variations in coding exons and flanking introns of the ELN gene and MLPA to detect duplications and deletions.

Worldwide, 6 accredited medical genetic laboratories in the EU and 10 in the US, listed in the Orphanet ([@ref17]) and GTR ([@ref18]) databases, respectively, offer genetic testing for SVAS. The guidelines for clinical use of genetic testing are described in Genetics Home Reference ([@ref19]).

Syndromes predisposing to aneurysm of large vessels {#sec1-3}
===================================================

Syndromes predisposing to aneurysm of large vessels are a group of inherited disorders that may affect different segments of the aorta, such as the aortic root, ascending aorta, aortic arch or descending aorta. They manifest as dilation, aneurysm or dissection of these segments. Aneurysms in the abdominal aorta, peripheral artery and cerebral artery are also reported ([@ref20]).

These syndromes may occur in isolation or associated with other genetic syndromes, including Marfan syndrome, Loeys-Dietz syndrome and Ehlers-Danlos syndrome. Some patients show one or more of the following clinical signs: congenital heart abnormalities, inguinal hernia, scoliosis and livedo reticularis.

Clinical symptoms vary widely. Aortic aneurysm usually has no symptoms, but depending on its growth rate, location and size, it may express as chest, back, jaw or neck pain, upper limb edema, dyspnea and/or dysphagia. Aortic dissections usually cause sudden severe chest or back pain and may be followed by hemorrhagic shock.

Familial thoracic aortic aneurysm and dissection is a frequent disorder. It is estimated to cause about 20% of all cases of thoracic aortic aneurysm and dissection ([@ref21]). The exact prevalence is not known as most aortic aneurysms do not cause symptoms unless there is dissection.

Clinical diagnosis is based on medical history, physical examination, transthoracic/transesophageal echocardiography, spiral computed tomography and invasive imaging methods such as left ventricular angiography and aortography ([@ref22]). Genetic testing is useful for confirming diagnosis of these aneurysm predisposition syndromes and for differential diagnosis, recurrence risk evaluation and prenatal diagnosis in families with a known mutation. Differential diagnosis should consider inherited disorders such as Marfan syndrome, Loeys-Dietz syndrome, Ehlers-Danlos syndrome and acquired disorders of thoracic aortic aneurysm, such as severe hypertension, atherosclerosis and infectious causes.

Syndromes predisposing to aneurysm of large vessels typically have autosomal dominant inheritance with reduced penetrance and variable expressivity ([@ref23]) ([Table 2](#T2){ref-type="table"}).

###### 

Genes associated with various forms of aneurysm of large vessels

  Gene        OMIM gene   Disease           OMIM disease   Inheritance   Function
  ----------- ----------- ----------------- -------------- ------------- ---------------------------------------------------------------------------------------------------------------
  *ACTA2*     102620      AAT6              611788         AD            Smooth muscle actin involved in vascular contractility and blood pressure homeostasis
  *COL3A1*    120180      EDSVASC           130050         AD            Expressed in extensible connective tissues as in the vascular system
  *ELN*       130160      ADCL1             123700         AD            Stabilization of arterial structure
  *FBN1*      134797      Marfan syndrome   154700         AD            Force-bearing structural support in elastic and nonelastic connective tissue as in blood vessels
  *FLNA*      300017      AAT               /              XLR           Role in blood vessels and heart development
  *FOXE3*     601094      AAT11             617349         AD            Aortic development
  *LOX*       153455      AAT10             617168         AD            Crosslinking of collagen and elastin
  *MFAP5*     601103      AAT9              616166         AD            Regulation of growth factors maintaining large vessel integrity
  *MYH11*     160745      AAT4              132900         AD            Major contractile protein
  *MYLK*      600922      AAT7              613780         AD            Facilitation of myosin interaction with actin filaments to produce contraction
  *PRKG1*     176894      AAT8              615436         AD            Regulation of cardiovascular function and relaxation of smooth muscle tone
  *SKI*       164780      SGS               182212         AD            Repressor of TGF-beta signaling, role in muscle differentiation
  *SLC2A10*   606145      ATORS             208050         AD            Required for cardiovascular system development
  *SMAD3*     603109      LDS3              613795         AD            Inhibitor of wound healing
  *SMAD6*     602931      AAT               /              AD            Modulation of endothelial gene expression
  *TGFB2*     190220      LDS4              614816         AD            Regulation of angiogenesis and heart development
  *TGFB3*     190230      LDS5              615582         AD            Involved in embryogenesis and cell differentiation, role in wound healing
  *TGFBR1*    190181      LDS1              609192         AD            Control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production
  *TGFBR2*    190182      LDS2              610168         AD            Control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production
  *MAT2A*     601468      AAT               /              XLR           Development of aortic arches

AAT=Familial aortic aneurysm, thoracic; EDSVASC=Ehlers-Danlos syndrome, vascular type; ADCL=autosomal dominant cutis laxa; SGS=Shprintzen-Goldberg craniosynostosis syndrome; ATORS=arterial tortuosity syndrome; LDS=Loeys-Dietz syndrome AD=autosomal dominant; XLR=X-linked recessive.

The mutation detection rate in patients with predisposition for aneurysm of large vessels is about 40% (specifically ACTA2 12-21%, FBN1 3%, FOXE3 1.4%, LOX 1.5%, MAT2A 1%, MFAP5 0.25%, MYH11 1%, MYLK 1%, PRKG1 1%, SMAD3 2%, TGFB2 1%, TGFBR1 3% and TGFBR2 5%) ([@ref24]). Pathogenic variants may be missense, nonsense, splicing or small indels. Large deletions/duplications have also been reported in COL3A1, ELN, FBN1, MYH11, SLC2A10 and SMAD3.

MAGI uses NGS to detect nucleotide variations in coding exons and flanking introns in the above genes and MLPA to detect duplications and deletions in COL3A1, ELN, FBN1, MYH11, SLC2A10 and SMAD3.

Worldwide, 46 accredited medical genetic laboratories in the EU and 39 in the US, listed in the Orphanet ([@ref17]) and GTR ([@ref18]) databases, respectively, offer gene tests for these aneurysm predisposition syndromes. The guidelines for clinical use of genetic testing are described in Genetics Home Reference ([@ref19]).

Conclusions {#sec1-4}
===========

We created a NGS panel to detect nucleotide variations in coding exons and flanking regions of all the genes associated with cardiac disorders. When a suspect of cardiac or aortic structural defects is present, we perform the analysis of all the genes present in this short article.

In order to have a high diagnostic yield, we developed a NGS test that reaches an analytical sensitivity (proportion of true positives) and an analytical specificity (proportion of true negatives) of ≥99% (coverage depth ≥10x).
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